Study on lymph node surgery for testicular cancer over 20 years
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study reviews 20 years of experience in removing lymph nodes in the abdomen (RPLND) for testicular cancer. It aims to understand the outcomes of this surgery for people who had it after chemotherapy or for early-stage cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You had surgery to remove residual lymph nodes in the abdomen after chemotherapy for testicular cancer, or you had this surgery as a primary treatment for early-stage testicular cancer (stage I or IIA-IIB) with normal tumor markers.
- You had this surgery by open, laparoscopic, or robotic technique.
- You are willing to give your consent to participate.
- You do not have bleeding disorders or other health conditions that make surgery unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two standard treatments—surgery to remove lymph nodes in the abdomen (RPLND) versus chemotherapy—for men with testicular cancer that has spread to a small area in the abdomen. The goal is to see which approach works better and has fewer side effects.
This trial tests if removing the involved lymph nodes in the abdomen (retroperitoneal lymph node dissection) is a good treatment for seminoma that has spread to a small number of lymph nodes. It may help patients avoid more chemotherapy or radiation.
This trial tests a newer, less invasive surgery using a dye called indocyanine green to find and remove lymph nodes in the back of the abdomen for early-stage testicular cancer. It compares this approach to the current standard procedure to see if it works just as well with fewer side effects.
This study looks at how removing lymph nodes in the back of the belly for testicular cancer affects urination and erectile function. It may help patients understand what to expect after this surgery.
This trial compares two surgical approaches for removing lymph nodes during prostate cancer surgery in men with high-risk disease on one side of the prostate. The goal is to determine whether removing lymph nodes from both sides or just one side provides better outcomes.
This trial studies whether a robotic operation (removing cancerous lymph nodes in the back of the belly) is a good first treatment for certain early-stage testicular seminoma cases. It aims to cure cancer while avoiding or delaying other treatments, and uses follow-up plans to check results.
Hear when a new Testicular Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.